Rizatriptan Benzoate
NDC Package 45865-844-18

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Rizatriptan Benzoate is a . Marketed by Mesource Pharmaceuticals, this product is identified by NDC 45865-844 and is authorized under FDA application ANDA200482.

Identification & Billing

NDC Package Code
45865-844-18
Package Description
18 BLISTER PACK in 1 CARTON / 6 TABLET in 1 BLISTER PACK
Product Code
45865-844
11-Digit Billing Format
45865084418

Clinical Specifications

Proprietary Name
Rizatriptan Benzoate
Dosage Form
-

Regulatory & Marketing

Labeler Name
Mesource Pharmaceuticals
FDA Application #
ANDA200482
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-31-2012
End Marketing Date
02-29-2016
Listing Expiration
02-29-2016
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 45865-844-18 identifies a specific commercial package of 18 blister pack in 1 carton / 6 tablet in 1 blister pack of Rizatriptan Benzoate, labeled by Mesource Pharmaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mesource Pharmaceuticals on December 31, 2012. The current certification is valid through February 29, 2016.

How is this Mesource Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 45865084418. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
45865-844-18
11-Digit CMS (5-4-2)
45865-0844-18

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.